2021-2022年中非共和国秘鲁陆军维和人员恶性疟原虫疟疾血清学监测
研究对部署至中非共和国的97名秘鲁陆军维和人员进行疟疾监测,部署期间疟疾患病率为33.33%,部署后检出4例疟疾病例(恶性疟原虫2例、卵形疟原虫1例、疟原虫属1例),IgG血清阳性率为31.96%,提示维和人员暴露风险高,需加强主动监测。
要点
- 部署期间疟疾患病率为33.33%(97名维和人员)。
- 部署后检出4例:恶性疟原虫2例、卵形疟原虫1例、疟原虫属1例。
- 恶性疟原虫MSP-1特异性IgG血清阳性率为31.96%。
核心结论
- 维和人员在部署期间恶性疟原虫暴露风险高,需对军人群体开展主动监测以降低疟原虫种和株输入美洲的风险。
研究设计与样本
- 对97名部署至中非共和国的秘鲁陆军维和人员进行部署后疟疾诊断(孔雀石绿环介导等温扩增和光诱导电子转移PCR)及ELISA检测恶性疟原虫MSP-1 C端19kDa区特异性IgG。
主要发现
- 部署期间通过显微镜和快速诊断试验识别疟疾病例,疟疾患病率为33.33%。
- 部署后检出4例疟疾病例:恶性疟原虫(n=2)、卵形疟原虫(n=1)、疟原虫属(n=1)。
- 97名维和人员中恶性疟原虫MSP-1特异性IgG血清阳性率为31.96%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Plasmodium falciparum infection threatens military populations deployed to highly malaria-endemic regions, such as Peruvian Army peacekeepers deployed to Central African Republic. During deployment, malaria cases were identified by microscopy and rapid diagnostic tests. After deployment, we performed malaria diagnosis by malachite green loop-mediated isothermal amplification and photo-induced electron transfer PCR assays. We used ELISA to test for P. falciparum C-terminal 19-kDa region merozoite surface protein 1-specific IgG from 97 peacekeepers. Malaria prevalence during deployment was 33.33% and we detected 4 cases after deployment: P. falciparum (n = 2), P. ovale (n = 1), and Plasmodium spp. (n = 1). IgG surveillance showed a seroprevalence of 31.96% in peacekeepers, who had a high P. falciparum exposure during deployment. Our findings reinforce the necessity of active surveillance in military populations to reduce the risk for introduction of new Plasmodium species and strains into the Americas from malaria-endemic areas.
引用
- Ventocilla JA, Valdivia HO, Ore M, et al. Serosurveillance for Plasmodium falciparum Malaria in Peruvian Army Peacekeeping Personnel, Central African Republic, 2021-2022. Emerg Infect Dis. 2024. PMID: 39530875. doi:10.3201/eid3014.240295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。